CLINICAL IMPACT OF ANTIMICROBIAL IMPREGNATED CATHETERS FOR PREVENTION OF INFECTION IN CEREBROSPINAL FLUID DIVERSION PROCEDURES
Author(s)
Parker E1, Velleca M2, Scagliarini L2
1DePuy Synthes, Leeds, UK, 2Johnson & Johnson Medical S.p.A., Pratica di Mare, Italy
OBJECTIVES: Infection is a common complication occurring during the treatment of hydrocephalus with shunts and has also been shown to be a high risk in external ventricular drains (EVDs). Increased risk of mortality and repeated surgeries are serious complications associated with catheter-related infections and hence reduction of infection is crucial. Additionally, treatment of infection represents a substantial cost to healthcare providers. Use of antimicrobial-impregnated catheters (AICs) provides a solution to help minimize risk of infection. The effectiveness of AICs in reducing rate of infection has been widely investigated; predominantly in observational cohort studies, but collective assessment of the literature is limited. The aim of this analysis is to collectively assess rate of infection in studies comparing non-AICs to AICs. METHODS: A structured literature review was performed to identify all available evidence. Relevant studies were identified in accordance strict inclusion/exclusion criteria. Data was extracted and overall infection rates calculated relative to the number of catheters evaluated in each study. RESULTS: A total of 23,688 procedures were assessed from 18 shunt studies and 2,515 procedures from 8 EVD studies. Use of AIC shunts was associated with a 37% lower mean rate of infection, with infection rates of 3.4% (range of study means 0% to 9.8%) and 5.5% (3.6% to 58.3%) for AICs and non-AICs, respectively. Use of AIC EVDs was associated with a 74% lower mean rate of infection, with infection rates of 3.5% (1% to 23.3%) and 13.2% (2.8% to 76.7%) for AICs and non-AICs, respectively. CONCLUSIONS: This analysis supports the effectiveness of AICs in helping minimize risk of infection in both shunt and EVD procedures. The reduction of infection associated with adoption of AICs could also serve as potential cost saving strategy for healthcare providers: AICs may be considered a valid solution to help minimize the risk of infection in shunt and EVD procedures.
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PMD11
Topic
Clinical Outcomes
Topic Subcategory
Comparative Effectiveness or Efficacy
Disease
Infectious Disease (non-vaccine)